Correction: Long non-coding RNAs in response to Ebola virus vaccine-induced immunity.

Saved in:
Bibliographic Details
Title: Correction: Long non-coding RNAs in response to Ebola virus vaccine-induced immunity.
Authors: Mamede I; Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Luschër-Dias T; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, Universidade de São Paulo, São Paulo, Brazil., Moscardini IF; Bios-Therapy, Physiological Systems for Health S.p.A., Sansepolcro, Italy., Gonzales-Dias P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Marinho B; Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Marcon F; Laboratory of Genetics and Molecular Cardiology (LGCM), InCor/Clinical Hospital FMUSP (HCMUSP), São Paulo, Brazil., Hirata TDC; Centre of Omics Technologies (CTO), School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Eichberg M; Strategic Alliances at Merck Research Laboratories, Boston, MA, United States., Medaglini D; Department of Medical Biotechnologies, Laboratory of Molecular Microbiology and Biotechnology, University of Siena, Siena, Italy., Harandi AM; Department of Microbiology & Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada., Siegrist CA; Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Ottenhoff THM; Leiden University Center of Infectious Diseases (LUCID), Leiden, Netherlands., Santoro F; Dipartimento di Biotecnologie Mediche, Università di Siena, Siena, Italy., Addo MM; Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; German Centre for Infection Research, partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany., Gonçalves A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Ferreira DM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Polidoro R; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States., Franco GR; Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Amaral PP; INSPER Institute of Education and Research, São Paulo, Brazil., Nakaya H; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, Universidade de São Paulo, São Paulo, Brazil.; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Institut Pasteur de São Paulo, São Paulo, Brazil.
Corporate Authors: VSV-EBOPLUS Consortium
Source: Frontiers in immunology [Front Immunol] 2026 Mar 03; Vol. 17, pp. 1809363. Date of Electronic Publication: 2026 Mar 03 (Print Publication: 2026).
Publication Type: Published Erratum
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1809363